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Why Pain Gets Worse: The Mechanism of Heat Hyperalgesia
Xuming Zhang and Peter A. McNaughton
Department of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK
Pain differs from other senses in many ways; one of the 
most striking is that the intensity of pain increases with 
time in the presence of a painful stimulus, a process 
that is referred to as sensitization or hyperalgesia. With 
all the other senses, the perceived intensity decreases 
with continuous exposure to a constant stimulus. For 
instance, when you emerge from a cinema onto a sunny 
street you are at fi rst dazzled, but soon adapt to the new 
and higher ambient light level. If vision behaved like 
pain the opposite would happen—the dazzling light of 
the street would become ever brighter. The reason for 
the difference is clear enough. Light adaptation allows 
us to operate over a wide range of ambient light intensi-
ties, a necessary property for any species that may at 
one moment be in bright sunlight and the next in a 
dark cave (possibly containing a bear). Pain, on the 
other hand, cannot be ignored as it often signals tissue 
damage, and it is essential for the integrity of the organ-
ism that a painful stimulus should become ever more 
pressing until the subject takes some action to remove 
its cause.
Thus hyperalgesia fulfi lls a valuable survival function, 
but it also has a major downside. When infl ammation is 
chronic, for instance in an arthritic joint, hyperalgesia 
can be disabling because the only action the subject can 
take is to remain immobile, not a strategy with positive 
implications for survival in an animal, nor for emotional 
or economic well being in a human. Many of the early 
investigations in empirical pharmacognosy, otherwise 
known as folk medicine, were directed toward alleviat-
ing the pain resulting from infl ammation. These inves-
tigations were conducted in a manner that we would 
now regard as highly unscientifi c, but they did score 
some notable successes. Amongst them were the discov-
ery of two potent analgesics, in the shape of salicylic 
acid from willow bark, and opium from poppies. The 
descendants of both are, of course, still in widespread 
use today.
Modern science has taken a more rational strategy 
 toward understanding hyperalgesia. We now recognize 
that it is not intrinsic to the pain-sensitive nerve termi-
nals themselves, but instead depends on the release of 
extracellular proinfl ammatory mediators from stressed 
or damaged tissue. These mediators are many and di-
verse in origin, but amongst the best studied are brady-
kinin, ATP, prostaglandin E2, and (surprisingly) nerve 
growth factor (NGF). NGF is of course a potent growth 
factor, which promotes the targeting of outgrowing 
nerve fi bers in the developing organism, but it also 
seems to play a role in the adult organism, as a pro-
infl ammatory mediator amongst its other roles (Lewin 
et al., 1993).
The paper by Stein et al. (2006), on p. 509 of this 
 issue, reports a highly interesting advance in our under-
standing of the molecular basis of hyperalgesia. The pa-
per focuses on the mechanism by which the heat-activated 
ion channel, transient receptor potential vanilloid 1 
(TRPV1), is sensitized by NGF. TRPV1 is one mecha-
nism (although not the only one) by which we detect 
mild levels of painful heat, and its activation at around 
43°C is likely to be responsible for the transition in the 
English language between the word “warm,” which has 
pleasant connotations and is used to describe heat 
 below 43°C, and “hot,” which signifi es an unpleasant 
heat sensation above this threshold temperature. TRPV1 
is strongly activated by increases in temperature >43°C, 
a property that sets it apart from most other ion chan-
nels, in which channel opening is only weakly tem-
perature sensitive. The activation of heat-sensitive ion 
channels in sensory neurons was fi rst characterized in 
work by Cesare and McNaughton (1996), and the rele-
vant channel (at fi rst named VR1) was subsequently 
cloned by the group of David Julius (Caterina et al., 
1997). An important property of TRPV1 is that the tem-
perature threshold is lowered by proinfl ammatory me-
diators such as bradykinin (Cesare and McNaughton, 
1996), in a process called heat hyperalgesia. This prop-
erty is the basis of the heat hyperalgesia caused by 
 infl ammation, because this aspect of hyperalgesia is 
abolished in mice from which TRPV1 has been deleted 
(Caterina et al., 2000; Davis et al., 2000).
As with any highly evolved function, heat hyperalgesia 
is a complex process to which several different mecha-
nisms can contribute. Which mechanism is recruited 
depends on the identity both of the infl ammatory 
 mediator and of the intracellular signaling pathways 
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 activated downstream of its binding to a receptor in the 
neuronal membrane. In roughly historical order, the 
proposed mechanisms are as follows:
(1) Phosphorylation by PKCε. Bradykinin, ATP, and many 
other infl ammatory mediators activate PKC, which in 
turn sensitizes the heat-activated current in neurons, 
which we now recognize as being carried by TRPV1 
(Cesare and McNaughton, 1996). The main isoform in-
volved is PKCε (Cesare et al., 1999), and serines 502 
and 800 are the critical sites for the sensitizing effect 
(Numazaki et al., 2002; Bhave et al., 2003) (NB residue 
numbers are from the rat TRPV1 sequence).
(2) Removal of Inhibition by Phosphatidyl Inositol 4,5-
 Bisphosphate (PIP2). An alternative pathway for the action 
of bradykinin, NGF, and other mediators that activate 
phospholipase C, leading to the metabolism of PIP2, was 
proposed by Chuang et al. (2001). The idea here is that 
PIP2 inhibits TRPV1 by binding directly to the ion channel, 
and that removal of PIP2 by PLC would lead to sensiti-
zation. This idea was supported by experiments  showing 
that application of either PLC or a PIP2-sequestering 
 antibody directly to TRPV1 expressed in membrane 
patches caused potentiation, and that deletion of a pro-
posed PIP2 binding domain in the C-terminal tail has 
a similar effect (Prescott and Julius, 2003).
(3) Phosphorylation by PKA. Prostaglandins and other 
infl ammatory mediators activate PKA, which in turn 
phosphorylates TRPV1. The main effect seems to be via 
serine 116, and to involve a reduction in desensitization 
rather than a sensitization per se (Bhave et al., 2002).
(4) Phosphorylation by Src. Work in our group has recently 
identifi ed a novel process by which NGF sensitizes TRPV1 
by rapidly increasing the number of ion channels in the 
cell membrane (Zhang et al., 2005). The incorporation 
of new channels depends on activation of PI3 kinase, 
which in turn activates the nonreceptor tyrosine kinase 
Src. Phosphorylation by Src of a single critical residue 
in TRPV1, tyrosine 199, triggers the rapid movement of 
TRPV1 channels to the surface membrane.
(5) Upregulation of Channel Expression. NGF has the more 
long-term effect of upregulating de novo expression of 
TRPV1. The pathway involved is the Ras-MAPK pathway 
rather than the PI3K-Src pathway outlined above (Ji et al., 
2002; Bron et al., 2003).
The role of mechanism 2, the relief of inhibition by 
PIP2, is a particular focus of the paper by Stein et al. 
(2006). Doubt already had been cast on this model by 
work from Qin’s group showing that stimulating the 
production of PIP2 enhances rather than inhibits re-
covery of TRPV1 from desensitization (Liu et al., 2005), 
and work from our lab, which showed that sensitization 
of TRPV1 by NGF can be explained by phosphoryla-
tion of TRPV1 by the tyrosine kinase Src, a mechanism 
completely independent of PIP2 (Zhang et al., 2005). 
However, one rather obvious experiment that does not 
appear to have been done before is to apply PIP2 di-
rectly to the cytoplasmic face of an isolated membrane 
patch. Stein et al. have performed this experiment, and 
the result is striking. Instead of inhibiting TRPV1, as 
predicted by the PIP2 inhibition model, PIP2 dramati-
cally potentiates the activation of TRPV1 by capsaicin. 
The effect of PIP2 itself is not completely reversible, pre-
sumably because the highly hydrophobic PIP2 molecule 
remains in the membrane patch, but the potentiation 
produced by a version of PIP2 with shorter carbon tails 
is readily reversible. In a second experiment, endoge-
nous PIP2 was removed by the highly cationic molecule 
polylysine. Instead of the potentiation expected in the 
original PIP2 model, the capsaicin-activated current was 
inhibited, and the inhibition could be reversed by sub-
sequent addition of PIP2. The basic tenet of the PIP2 
model therefore does not seem to hold up; PIP2 does 
not inhibit TRPV1, but instead potently enhances its 
 activation. A similar enhancement of a number of other 
members of the TRP family of ion channels by PIP2 has 
been described (for review see Hardie, 2006). Thus, in 
the end, TRPV1 seems to be similar to many other TRP 
channels, in that its activation is potentiated by PIP2, 
rather than being an “outlier” that is inhibited by PIP2.
Stein et al. next investigated the cellular signaling 
pathways by which activated TrkA potentiates TRPV1. 
Several largely independent signaling pathways radiate 
from activated TrkA. Three well-characterized down-
stream pathways involve PLCγ, PI3 kinase, and Ras-MAP 
kinase (Kaplan and Miller, 2000). In agreement with 
earlier studies (Bonnington and McNaughton, 2003; 
Zhuang et al., 2004; Zhang et al., 2005), Stein et al. found 
that the effect of NGF was abolished by wortmannin, 
an inhibitor of PI3 kinase. They make one new observa-
tion, though, which was not present in earlier accounts; 
they show that the p85β subunit of PI3K interacts 
 directly with TRPV1 via its SH2 domain. Yeast 2-hybrid 
experiments using the N terminus of TRPV1 as bait 
identify the p85β subunit of PI3K as a binding partner; 
coimmunoprecipitation experiments show that TRPV1 
and p85β bind to one another; and experiments in 
which various domains of p85β were isolated and tested 
for their ability to bind to TRPV1 in coimmunopre-
cipitation experiments show that only the SH2 domain 
bound TRPV1 to any signifi cant extent. However, two 
aspects of the binding are unexpected: fi rst, the bind-
ing was not found to be promoted by NGF, as might 
have been expected if PI3K is targeted to TRPV1 after 
activation of TrkA; and second, Stein et al. were unable 
to fi nd any evidence that TRPV1 was phosphorylated on 
tyrosine residues. This last result is surprising because 
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the function of SH2 domains is to bind to phosphotyro-
sine residues, and the fact that the SH2 domain of p85β 
binds to TRPV1 thus seems to imply that there must 
be some phosphotyrosine residues present in TRPV1. 
Zhang et al. (2005) have shown that tyrosines in TRPV1 
are phosphorylated and that the phosphorylation is en-
hanced when TrkA is activated by NGF.
The fi nal major area covered by Stein et al. relates to 
the mechanism by which NGF causes potentiation of 
TRPV1. Previous studies have identifi ed a change in the 
activation properties of TRPV1 after phosphorylation 
by PKCε: the temperature threshold for activation is 
lowered, and the dose–response relation for capsaicin 
shifts to lower capsaicin concentrations (mechanism 1 
above; see Vellani et al., 2001). A second effect has been 
reported more recently: the number of TRPV1 chan-
nels in the membrane was found to be enhanced, after 
exposure to NGF, by a rapid translocation of TRPV1 
channels from a cytoplasmic pool (Zhang et al., 2005). 
Stein et al. confi rmed that the maximum current acti-
vated by a saturating concentration of capsaicin is in-
creased by NGF. In addition they demonstrated that 
TRPV1 is rapidly translocated to the membrane by an 
elegant experiment in which the density of GFP-tagged 
channels in the membrane was directly visualized using 
total internal refl ection (TIRF) microscopy.
What happens downstream of PI3K is still an open 
question. Work in our group shows that Src is activated, 
binds to TRPV1, and phosphorylates residue Y199 (Y200 
in the human sequence); this phosphorylation could be 
a signal for translocation of TRPV1 to the membrane. Stein 
et al. suggest that the binding of PI3K to TRPV1 itself me-
diates translocation of TRPV1 to the surface membrane. 
Clearly there is a need for further experiments.
A satisfying degree of agreement is now beginning to 
emerge on most aspects of potentiation of TRPV1. Of 
the mechanisms outlined above, numbers 1 and 3–5 are 
still looking strong. In the case of mechanism 2, how-
ever, the emerging consensus is that the PIP2 mecha-
nism is not important in heat hyperalgesia, in direct 
contradiction to previous studies (Chuang et al., 2001; 
Prescott and Julius, 2003). The Stein et al. article raises 
the tantalizing possibility that PIP2 may yet play a role, 
but as a potentiator of TRPV1 rather than as an inhibitor. 
The physiological role of this mechanism remains to 
be elucidated.
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